Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Clinical Apheresis|October 20, 2004
Assessment of complement activation during membrane-based plasmapheresis proceduresThierry Burnouf, Michel Eber, Daniel Kientz, et al.
Transfusion|April 11, 2015
Comparative effectiveness of plasma prepared with amotosalen-UVA pathogen inactivation and conventional plasma for support of liver transplantationJacques Cinqualbre, Daniel Kientz, Emilie Remy, et al.
Thrombosis and Haemostasis|September 28, 2006
Plasma glycoprotein V levels in the general population: normal distribution, associated parameters and implications for clinical studiesBoris Aleil, Nicolas Meyer, Valérie Wolff, et al.
Transfusion|August 24, 2023
Biochemical and functional characteristics of stored (double-dose) buffy-coat platelet concentrates treated with amotosalen and a prototype UVA light-emitting diode illuminatorNathalie Brouard, Floriane Pissenem-Rudwill, Clarisse Mouriaux, et al.
Transfusion|January 16, 2008
Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centersPeter Schlenke, Tor Hervig, Hervé Isola, et al.
Transfusion|September 21, 2010
Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year periodJean-Pierre Cazenave, Hervé Isola, Chantal Waller, et al.
Transfusion|March 26, 2019
Hypersensitivity transfusion reactions to platelet concentrate: a retrospective analysis of the French hemovigilance networkPaul M Mertes, Charles Tacquard, Georges Andreu, et al.
Transfusion|March 25, 2009
Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La RéunionPatrice Rasonglès, Marie France Angelini-Tibert, Philip Simon, et al.
Blood Transfusion = Trasfusione Del Sangue|September 3, 2025
Clinical impact of Amotosalen and UV-A treatment (INTERCEPT™ Blood System) for platelet concentrate preparation in cardiac surgeryPaul-Michel Mertes, Walid Oulehri, Philippe Gomis, et al.
Transfusion|February 2, 2010
An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatmentJean-Pierre Cazenave, Chantal Waller, Daniel Kientz, et al.
Pageof 2